Sponsors
The bill provides a targeted compensation program and safeguards (tax and benefits exclusions) for thalidomide survivors and builds oversight, but its narrow eligibility rules, one‑time payment design, and reliance on annual appropriations create persistent funding, sufficiency, and fairness trade‑offs for survivors and taxpayers.
Thalidomide survivors who were U.S. citizens or lawful permanent residents at the time of exposure and at filing will be eligible for a one-time $150,000 payment when the review panel finds exposure caused their injury.
Compensation and additional survivor payments will not be treated as income or assets for means-tested federal programs, protecting recipients' eligibility for SNAP, SSI, Medicaid, and similar benefits.
Compensation paid to survivors will be excluded from taxable income and the law simplifies tax filing for recipients by removing the need to report these payments as taxable income.
Eligibility is narrowly limited: only U.S. citizens or lawful permanent residents at exposure and at filing are eligible, and some provisions limit assistance to a small, well‑defined group, excluding other survivors.
The $150,000 payment is a one‑time fixed amount that may be insufficient to cover lifetime medical, caregiving, and disability-related costs for many survivors.
Payments and additional compensation depend on annual appropriations (2028–2034) and availability of funds, creating uncertainty, potential delays, and risk of intermittent or reduced payments.
Based on analysis of 7 sections of legislative text.
Creates a federal program paying $150,000 to qualifying U.S. residents injured by prenatal thalidomide exposure, excludes payments from income and means-tested benefit calculations, and adds a tax exclusion.
Introduced October 28, 2025 by Jefferson Van Drew · Last progress October 28, 2025
Creates a federal compensation program that pays $150,000 to qualifying people in the United States who were injured by prenatal exposure to thalidomide. The Department of Health and Human Services must set up the program within one year, use an expert panel to review single petitions supported by medical documentation, and close petition filing after May 31, 2034. Payments are excluded from taxable income and are not counted as income or assets for means-tested federal benefit programs. The law authorizes additional payments subject to appropriations, requires annual program reviews with reports to Congress, and adds a tax-code exclusion for program payments.